homocysteine has been researched along with fibrin in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 15 (62.50) | 29.6817 |
| 2010's | 6 (25.00) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Borth, W; Chang, VT; Harpel, PC | 1 |
| Dardik, R; Salomon, O; Savion, N; Shenkman, B; Tamarin, I; Varon, D; Zivelin, A | 1 |
| Jacobsen, DW; Kinter, MT; Majors, AK; Pyeritz, RE; Sengupta, S; Willard, B | 1 |
| Kordich, LC; Lauricella, AM; Quintana, IL | 1 |
| Hoffman, M; Sauls, DL; Wolberg, AS | 1 |
| Anglés-Cano, E; Durlach, V; Nardulli, M; Pepe, G | 1 |
| Durga, J; Klerk, M; Kluft, C; Kok, FJ; Schouten, EG; Verhoef, P | 1 |
| Dávid, M; Habon, T; Keszthelyi, Z; Kovács, N; Losonczy, H; Nagy, A; Tóth, O | 1 |
| Hoffman, M; Lenkowski, A; Lockhart, E; Sauls, DL; Warren, ME; Wilhelm, SE | 1 |
| Brozek, J; Jakubowski, H; Jankowski, M; Siudak, Z; Szczeklik, A; Undas, A | 1 |
| Castañon, M; Kordich, L; Lauricella, AM; Quintana, I; Sassetti, B | 1 |
| Drwiła, R; Plicner, D; Sadowski, J; Stepień, E; Undas, A | 1 |
| Carvajal, Z; Marchi, R; Weisel, JW | 1 |
| Kordich, L; Lauricella, AM; Oberholzer, MV; Quintana, IL | 1 |
| Kapelak, B; Plicner, D; Sadowski, J; Stepień, E; Undas, A; Wypasek, E | 1 |
| Almeida, D; Broekman, MJ; Deora, AB; Greenberg, CB; Hajjar, KA; Jacovina, AT; Ling, Q; Marcus, AJ; Smith, JD | 1 |
| Kordich, L; Lauricella, AM; Rojas, AM | 1 |
| Bald, E; Glowacki, R; Jeziorski, A; Kedzierska, M; Malinowska, J; Olas, B; Piekarski, J | 1 |
| Malinowska, J; Olas, B | 1 |
| Karska-Basta, I; Kubicka-Trząska, A; Romanowska-Dixon, B; Undas, A | 1 |
| Genoud, V; Kordich, LC; Lauricella, AM; Quintana, I | 1 |
| Nowak, P; Tadeusiewicz, J | 1 |
| Jakubowski, H; Perła-Kaján, J; Sikora, M; Skrzydlewski, P | 1 |
| Głowacki, R; Klajmon, A; Kopiński, P; Natorska, J; Piechocka, J; Ząbczyk, M | 1 |
2 review(s) available for homocysteine and fibrin
| Article | Year |
|---|---|
[Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
Topics: Adult; C-Reactive Protein; Cholesterol; Cysteine; Female; Fibrin; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Pedigree; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Risk Factors; Threonine; Thrombophilia; Thrombosis; Venous Thrombosis; von Willebrand Factor | 2005 |
[The role of post-translational modification of fibrinogen in the pathogenesis of thrombosis].
Topics: Extracellular Space; Fibrin; Fibrinogen; Fibrinolysis; Glycation End Products, Advanced; Halogenation; Homocysteine; Humans; Lysine; Protein Processing, Post-Translational; Thrombosis | 2015 |
2 trial(s) available for homocysteine and fibrin
| Article | Year |
|---|---|
No effect of folic acid supplementation in the course of 1 year on haemostasis markers and C-reactive protein in older adults.
Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Dietary Supplements; Factor VIIa; Female; Fibrin; Folic Acid; Hemostasis; Homocysteine; Humans; Inflammation; Male; Middle Aged; Placebos; Risk; Thromboplastin; Time Factors; von Willebrand Factor | 2005 |
Homocysteine thiolactone contributes to the prognostic value of fibrin clot structure/function in coronary artery disease.
Topics: Coronary Artery Disease; Fibrin; Folic Acid; Homocysteine; Humans; Myocardial Infarction; Prognosis; Risk Factors; Thrombosis; Vitamin B 12; Vitamin B Complex | 2022 |
20 other study(ies) available for homocysteine and fibrin
| Article | Year |
|---|---|
Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.
Topics: Blotting, Western; Chromatography, Gel; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Fibrin; Fibrinolysin; Homocysteine; Humans; Kinetics; Lipoprotein(a); Protein Binding; Sulfhydryl Compounds | 1992 |
Homocysteine and oxidized low density lipoprotein enhanced platelet adhesion to endothelial cells under flow conditions: distinct mechanisms of thrombogenic modulation.
Topics: Abciximab; Antibodies; Antibodies, Monoclonal; Calcium; Cell Adhesion Molecules; Endothelium, Vascular; Fibrin; Fibrinogen; Homocysteine; Humans; Immunoglobulin Fab Fragments; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Oxidation-Reduction; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Cell Surface; Receptors, Vitronectin; Thromboplastin; Umbilical Veins | 2000 |
Homocysteine binds to human plasma fibronectin and inhibits its interaction with fibrin.
Topics: Arteriosclerosis; Binding, Competitive; Fibrin; Fibronectins; Gelatin; Homocysteine; Humans; In Vitro Techniques; Muscle, Smooth, Vascular; Thrombosis | 2002 |
Effects of homocysteine thiol group on fibrin networks: another possible mechanism of harm.
Topics: Blood Coagulation; Fibrin; Homocysteine; Humans; Kinetics; Microscopy, Electron, Scanning; Sulfhydryl Compounds; Thrombin; Thrombosis | 2002 |
Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia.
Topics: Animals; Blood Coagulation; Fibrin; Fibrinogen; Fibrinolysin; Homocysteine; Hyperhomocysteinemia; In Vitro Techniques; Microscopy, Electron, Scanning; Rabbits; Thrombosis | 2003 |
Mechanism for the homocysteine-enhanced antifibrinolytic potential of lipoprotein(a) in human plasma.
Topics: Antifibrinolytic Agents; Blotting, Western; Cell Line; Disulfides; Dose-Response Relationship, Drug; Fibrin; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Immunoblotting; Ligands; Lipoprotein(a); Phenotype; Plasminogen; Protein Binding; Protein Isoforms; Protein Structure, Tertiary; Recombinant Proteins; Risk Factors; Structure-Activity Relationship; Transfection | 2005 |
Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
Topics: Amino Acid Sequence; Blood Coagulation; Dose-Response Relationship, Drug; Fibrin; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Lysine; Models, Biological; Molecular Sequence Data; Plasminogen; Protein Binding; Radiation-Protective Agents; Structure-Activity Relationship; Thrombosis; Tissue Plasminogen Activator | 2006 |
Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects.
Topics: Acute Disease; Adult; Aged; Blood Coagulation; Case-Control Studies; Coronary Artery Disease; Diabetes Mellitus; Drug Resistance; Fibrin; Fibrinolytic Agents; Folic Acid; Hematinics; Homocysteine; Humans; Hypercholesterolemia; Hyperhomocysteinemia; Male; Middle Aged; Permeability; Recombinant Proteins; Tissue Plasminogen Activator | 2006 |
Influence of homocysteine on fibrin network lysis.
Topics: Blood Coagulation; Fibrin; Fibrinolysin; Fibrinolysis; Homocysteine; Humans; Microscopy, Electron; Plasma; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Plasminogen Inactivators | 2006 |
Altered fibrin clot structure in patients with advanced coronary artery disease: a role of C-reactive protein, lipoprotein(a) and homocysteine.
Topics: Aged; C-Reactive Protein; Case-Control Studies; Coronary Artery Disease; Female; Fibrin; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged | 2007 |
Comparison of the effect of different homocysteine concentrations on clot formation using human plasma and purified fibrinogen.
Topics: Blood Coagulation; Factor XIII; Fibrin; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia | 2008 |
Impaired fibrin gel permeability by high homocysteine levels.
Topics: Factor XIII; Fibrin; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Hyperhomocysteinemia; Linear Models; Permeability | 2011 |
Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
Topics: Aged; C-Reactive Protein; Case-Control Studies; Coronary Artery Bypass; Coronary Artery Disease; Factor XIII; Female; Fibrin; Fibrinolysis; Homocysteine; Humans; Male; Middle Aged; Permeability; Polymorphism, Genetic; Risk Assessment | 2009 |
Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis.
Topics: Animals; Annexin A2; Cell Movement; Corneal Neovascularization; Diet; Endothelial Cells; Fibrin; Fibrinolysis; Homocysteine; Hyperhomocysteinemia; Male; Methionine; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; Recombinant Proteins | 2009 |
Homocysteine modifies fibrin clot deformability: another possible explanation of harm.
Topics: Blood Coagulation; Elasticity; Fibrin; Homocysteine; Humans; Thrombosis | 2009 |
The elevated homocysteine stimulates changes of haemostatic function of plasma isolated from breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Case-Control Studies; Female; Fibrin; Fibrinolysis; Hemostasis; Homocysteine; Humans; Middle Aged; Risk Factors; Statistics, Nonparametric; Thrombin Time | 2011 |
Analysis of biological properties of selected elements of haemostasis after treatment with the oxidized form of homocysteine in vitro.
Topics: Adult; Blood Coagulation; Blood Platelets; Fibrin; Fibrinolysis; Homocysteine; Humans; Oxidation-Reduction; Platelet Aggregation; Protein Multimerization | 2011 |
Altered fibrin clot properties in patients with retinal vein occlusion.
Topics: C-Reactive Protein; Coronary Artery Disease; Female; Fenofibrate; Fibrin; Fibrinolysis; Heptanoic Acids; Homocysteine; Humans; Hypersensitivity, Immediate; Laser Coagulation; Lipoprotein(a); Male; Pyrroles; Retinal Vein; Retinal Vein Occlusion; Simvastatin; Tetrahydroisoquinolines; Thrombosis; Venous Thromboembolism; Venous Thrombosis | 2011 |
Impact of homocysteine-thiolactone on plasma fibrin networks.
Topics: Animals; Blood Coagulation; Cattle; Fibrin; Homocysteine; Humans; Plasma | 2014 |
Plasma thiol levels and methylenetetrahydrofolate reductase gene c.665C > T and c.1286A > C variants affect fibrin clot properties in Polish venous thromboembolic patients.
Topics: Fibrin; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Poland; Sulfhydryl Compounds; Thrombosis; Venous Thromboembolism | 2023 |